Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?

Article English OPEN
Fanos, Vassilios; Pusceddu, Michele; Dessì, Angelica; Marcialis, Maria Antonietta; (2011)
  • Publisher: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
  • Journal: Clinics,volume 66,issue 12,pages2,141-2,149 (issn: 1807-5932, eissn: 1980-5322)
  • Related identifiers: doi: 10.1590/S1807-59322011001200022, pmc: PMC3226612
  • Subject: Preterm Newborn | R5-920 | Review | Medicine (General) | Ductus Arteriosus | Indometacin | NSAIDs | Ductus Arteriosus, Preterm Newborn, Prophilaxis, Indometacin, NSAIDs | Prophilaxis

Although the prophylactic administration of indomethacin in extremely low-birth weight infants reduces the frequency of patent ductus arteriosus and severe intraventricular hemorrhage, it does not appear to provide any long-term benefit in terms of survival without neur... View more
Share - Bookmark